Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Chinook Therapeutics, Inc. (KDNY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.64+0.65 (+3.25%)
At close: 04:00PM EDT
21.58 +0.94 (+4.55%)
After hours: 04:12PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close19.99
Open20.22
Bid19.70 x 900
Ask20.62 x 900
Day's Range19.99 - 21.05
52 Week Range10.48 - 21.11
Volume423,265
Avg. Volume708,417
Market Cap1.272B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.96
Earnings DateNov 01, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est34.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for KDNY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Chinook Therapeutics, Inc.
    Analyst Report: Pfizer Inc.Pfizer is a leading global developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs, treatments for rare diseases, and vaccines.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement